Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-041167
Filing Date
2022-11-14
Accepted
2022-11-14 07:50:43
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10043505_10q.htm   iXBRL 10-Q 1040511
2 EXHIBIT 31.1 brhc10043505_ex31-1.htm EX-31.1 11297
3 EXHIBIT 31.2 brhc10043505_ex31-2.htm EX-31.2 11283
4 EXHIBIT 32.1 brhc10043505_ex32-1.htm EX-32.1 4989
5 EXHIBIT 32.2 brhc10043505_ex32-2.htm EX-32.2 5223
  Complete submission text file 0001140361-22-041167.txt   5146679

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20220930.xsd EX-101.SCH 39611
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20220930_cal.xml EX-101.CAL 33532
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20220930_def.xml EX-101.DEF 210554
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20220930_lab.xml EX-101.LAB 545948
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20220930_pre.xml EX-101.PRE 342085
52 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043505_10q_htm.xml XML 679840
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 221380353
SIC: 2834 Pharmaceutical Preparations